This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Volume Progression in Autosomal Dominant Polycystic Kidney Disease: The Major Factor Determining Clinical Outcomes
Jump to section
More in this TOC Section
Cited By...
- Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease
- Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease
- Novel Treatments of Autosomal Dominant Polycystic Kidney Disease
- Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease
- Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
- Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
- Glomerular Hyperfiltration and Renal Progression in Children with Autosomal Dominant Polycystic Kidney Disease
- Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease
- Water Prescription in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study
- Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
- The HALT Polycystic Kidney Disease Trials: Design and Implementation
- Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients not yet on Dialysis
- Strategies to Inhibit Cyst Formation in ADPKD